Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
HCV-geïnduceerde epigenetische veranderingen geassocieerd met HCC-risico na SVR
sep 2019 | Hepatitis